Avantra

Avantra said that TD2's pharma clients could use its platform to identify appropriate biomarkers for use with drugs in development.

New Product Watch

Premium

Avantra Biosciences' Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay, Akonni Biosystems' TruSentry System, Agilent Technologies' BenchBot Robot, Exiqon's Mircury LNA microRNA Labeling Kits

Avantra was founded last year by Courtagen Capital Group to commercialize the assets of Decision Biomarkers, a protein biomarker technology firm that shuttered its business and filed for Chapter 7 bankruptcy in December 2009.

Formed from what had been Decision Biomarkers, Avantra is eyeing a launch of its biomarker detection platform in early 2011.

The company is being launched by Courtagen Capital Group using assets from defunct biotech firm Decision Biomarkers, which Courtagen purchased in bankruptcy court last December.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.